Ketamine Therapy for Treatment-Resistant Depression: Clinical Evidence and Patient Outcomes

Last Updated: August 14, 2026

Key Takeaways

Ketamine works fast and differently. Where standard antidepressants take weeks, ketamine can lift severe depression within hours to days by acting on the brain’s glutamate system.
It’s built for treatment-resistant depression. Its clearest role is for people who haven’t improved after multiple conventional antidepressants.
The evidence is strong for rapid relief. Esketamine (Spravato) earned FDA approval after trials showed meaningful benefit, including for acute suicidal thinking.
Durability takes a plan. Effects can fade without maintenance dosing and, increasingly, structured psychotherapy alongside treatment.
It’s a supervised medical treatment. Ketamine is given under monitoring because of dissociative and cardiovascular effects — not a take-home pill.

For someone whose depression hasn’t budged after trying one antidepressant after another, hope wears thin. Ketamine therapy has genuinely changed that conversation, offering rapid relief where little else worked. But it’s also surrounded by hype, confusion, and a fair amount of marketing noise.

This is a clear-eyed look at what ketamine therapy actually is, what the clinical evidence shows, and what patients can realistically expect from it as a treatment for depression and related conditions.

Los Angeles Mental Health

What Is Ketamine Therapy and How It Differs From Traditional Antidepressants

Ketamine began life as an anesthetic. At lower, carefully controlled doses, researchers discovered it produces rapid antidepressant effects unlike anything in the standard toolkit. That discovery, led by researchers at the National Institute of Mental Health, eventually produced esketamine (Spravato), a nasal-spray form the FDA approved for treatment-resistant depression in 2019.

The core difference is speed and target. Traditional antidepressants like SSRIs work on serotonin and typically take four to six weeks to help. Ketamine works on a different system entirely and can produce relief within hours — a critical distinction for someone in acute distress.

Feature	Ketamine Therapy	Traditional Antidepressants
Onset of relief	Hours to days	Four to six weeks or longer
Main brain target	Glutamate (NMDA receptors)	Serotonin, norepinephrine
How it’s given	IV infusion or nasal spray, in clinic	Daily oral pill at home
Supervision	Monitored medical setting	Self-administered
Best suited for	Treatment-resistant depression	First-line depression treatment

Because it’s delivered under supervision and carries real effects, ketamine therapy sits in a different category from routine prescriptions — closer to a procedure than a pill.

The Mechanism Behind Rapid Symptom Relief

Ketamine blocks NMDA receptors, triggering a surge of glutamate, the brain’s most abundant signaling chemical. That surge appears to prompt synaptogenesis — the rapid growth of new connections between neurons in regions that depression tends to wear down. In effect, ketamine seems to help the brain rebuild circuitry rather than just adjusting chemical levels. This regrowth is the leading explanation for why relief arrives so quickly compared with drugs that slowly shift serotonin.

Clinical Evidence Supporting Ketamine-Assisted Therapy for Mood Disorders

The research foundation is substantial and growing. In the landmark NIMH studies, a single intravenous dose of ketamine produced significant antidepressant effects in a majority of participants with treatment-resistant depression, with a meaningful share reaching remission — results that were remarkable given how little these patients had responded to prior treatment. Those findings paved the way for the phase III esketamine trials that led to FDA approval.

Research Outcomes in Treatment-Resistant Depression Cases

Treatment-resistant depression — depression that hasn’t responded to at least two adequate antidepressant trials — is where ketamine has shown its clearest value. Patients with TRD are at the highest risk of chronic illness and suicide, and the Department of Veterans Affairs is running large studies comparing esketamine against other add-on strategies precisely because the need is so urgent. Across trials, a substantial portion of TRD patients respond, and esketamine has also been studied specifically for reducing acute suicidal ideation.

Long-Term Efficacy and Sustained Improvements

The honest caveat is durability. A single treatment rarely holds indefinitely; benefits often fade within days to weeks without a maintenance plan. That’s why protocols typically involve a series of sessions followed by spaced maintenance dosing tailored to the individual. Increasingly, clinicians pair ketamine with psychotherapy to help those gains stick, which is where mood disorder treatment is heading.

The Role of Psychotherapy in Ketamine Treatment Protocols

Ketamine appears to open a window of heightened neuroplasticity — a period when the brain is unusually able to form new patterns. Ketamine-assisted psychotherapy aims to use that window deliberately, pairing the medication with structured therapy so the biological reset is matched by psychological change. The medication can lift the fog enough for someone to engage in the therapeutic work that produces lasting improvement, rather than relying on the drug alone.

Dissociative Disorders and Anxiety Disorders: When Ketamine Therapy Becomes Essential

Ketamine reliably produces temporary dissociation — a sense of detachment from the body or surroundings — during treatment. For most patients, this is a manageable, time-limited effect, and some researchers believe the experience itself may play a role in the therapeutic response. For people with certain anxiety disorders that haven’t responded to standard care, ketamine is being explored as an option when little else has helped, always with careful screening.

Managing Dissociative Symptoms During Treatment Sessions

Because dissociation is expected, good protocols plan for it. Patients are prepared beforehand about what to anticipate, treated in a calm and controlled environment, and monitored throughout for blood pressure and psychological comfort. The effects typically resolve within an hour or two of the session ending. Screening matters too: a history of psychosis or certain dissociative conditions calls for extra caution and careful clinical judgment about whether ketamine is appropriate.

PTSD Treatment and Trauma Recovery Through Therapeutic Ketamine

Beyond depression, therapeutic ketamine is an active area of trauma research. Because PTSD and depression frequently overlap and share underlying circuitry, researchers and the VA’s National Center for PTSD continue to study how rapid-acting treatments might help trauma survivors, particularly those who haven’t responded to first-line therapies. The evidence here is younger than for depression, so ketamine for PTSD is best understood as promising and evolving rather than settled.

Los Angeles Mental Health

How Ketamine Addresses the Neurobiological Roots of Trauma

Trauma appears to entrench rigid fear patterns in the brain. The same neuroplasticity that helps ketamine relieve depression may make traumatic memories more amenable to change — opening a window in which, paired with therapy, fear responses can be revisited and updated rather than simply re-triggered. This is why trauma-focused protocols emphasize combining ketamine with skilled psychotherapy rather than using the medication in isolation.

Patient Outcomes and Real-World Results From Mental Health Therapy Integration

In real-world practice, outcomes are encouraging but individual. Many people with long histories of treatment-resistant depression experience meaningful relief, sometimes for the first time in years. The strongest results tend to come from integrated care — ketamine delivered within a broader plan that includes therapy, monitoring, and attention to sleep, relationships, and underlying stressors. Ketamine is a powerful tool, not a cure-all, and setting realistic expectations is part of good treatment.

Personalized Treatment Plans at Los Angeles Mental Health for Depression Management

If depression hasn’t responded to previous treatments, ketamine therapy may be worth exploring — but only as part of a thorough, personalized evaluation. The right plan depends on your history, your diagnosis, and your goals, and it should always include proper medical supervision.

Los Angeles Mental Health offers comprehensive evaluation and individualized depression care, helping you understand whether ketamine therapy fits your situation and how it can work alongside other treatments. Reach out to start the conversation. If you’re in crisis, call or text 988.

Los Angeles Mental Health

FAQs

How quickly does ketamine-assisted therapy produce results compared to traditional antidepressants?

Much faster. Traditional antidepressants generally take four to six weeks to reach full effect, while ketamine can produce noticeable relief within hours to a few days. That speed is one of its most important advantages, especially for people in acute distress or at risk of suicide.

Can ketamine therapy help patients who haven’t responded to multiple depression medications?

Yes — that’s its primary role. Ketamine and FDA-approved esketamine are specifically indicated for treatment-resistant depression, meaning depression that hasn’t improved after at least two adequate antidepressant trials. Research consistently shows a substantial portion of these patients respond when little else has worked.

What happens during a dissociative experience in ketamine treatment sessions?

Many patients feel a temporary sense of detachment from their body or surroundings, sometimes with altered perception of time or space. It can feel strange but is usually not distressing when patients are prepared for it and monitored in a calm setting. The effect is dose-related and time-limited, typically resolving within an hour or two after the session. Clinicians watch vital signs and comfort throughout.

Why is psychotherapy integration crucial for sustained ketamine therapy outcomes?

Ketamine appears to open a window of heightened brain plasticity, making it easier to form new patterns of thought and behavior. Pairing that window with structured psychotherapy helps translate the biological reset into lasting psychological change, rather than relying on the medication alone.

How does therapeutic ketamine address trauma differently than standard PTSD treatment approaches?

Standard PTSD treatments like trauma-focused therapy work gradually to reprocess traumatic memories. Ketamine may accelerate that process by temporarily increasing neuroplasticity, potentially making entrenched fear responses more open to change when combined with therapy. It also acts rapidly on co-occurring depression and suicidal thinking.